Cross Country Healthcare (CCRN) Earnings Call Transcript
Trade with 70% Backtested Accuracy
Analyst Views on CCRN
About CCRN
About the author
Cross Country Healthcare Q4 Earnings Preview
- Earnings Announcement Date: Cross Country Healthcare (CCRN) is set to release its Q4 2023 earnings on March 4th after market close, with consensus EPS estimate at $0.03, reflecting a 25% year-over-year decline, and revenue expected at $254.3 million, down 17.9% year-over-year, indicating significant challenges ahead for the company.
- Historical Performance Review: Over the past two years, CCRN has beaten EPS estimates 50% of the time and revenue estimates 63% of the time, suggesting a degree of capability to exceed expectations, yet the recent downward revisions may undermine investor confidence.
- Expectation Revision Trends: In the last three months, EPS estimates have seen one upward revision and three downward revisions, while revenue estimates have experienced no upward revisions and four downward revisions, reflecting a cautious market outlook that could lead to stock price volatility.
- Merger Termination Impact: CCRN recently terminated its merger with Aya Holdings, which will incur a $20 million fee, and while this decision may negatively impact stock prices in the short term, it also provides the company with greater flexibility for future independent growth.
Cross Country Healthcare (CCRN) Earnings Call Transcript
Cross Country Healthcare Q4 Earnings Miss Expectations
- Earnings Miss: Cross Country Healthcare reported a Q4 non-GAAP EPS of -$0.06, missing expectations by $0.09, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company’s Q4 revenue of $236.8M represents a 23.6% year-over-year decline, falling short by $17.5M, reflecting weak market demand and intensified competition, which may hinder future growth prospects.
- Future Guidance: Management's guidance for Q1 2026 revenue is set at $235M to $240M, projecting a year-over-year decline of 20% to 18%, indicating a lack of confidence in short-term recovery, which could affect shareholder investment decisions.
- Adjusted EBITDA Outlook: The expected adjusted EBITDA range of $4.0M to $5.0M reflects a year-over-year decline of 54% to 42%, highlighting significant challenges in cost control and operational efficiency that may impact the company’s competitive position in the market.
Cross Country Healthcare to Hold Q4 2025 Earnings Call
- Earnings Call Scheduled: Cross Country Healthcare will hold a conference call on March 4, 2026, at 5:00 PM ET to discuss its Q4 and full-year 2025 financial results, with the earnings press release set to be distributed after market close, aiming to keep investors informed of the latest financial performance.
- Live Webcast and Replay: The call will be webcast live on the company's website, with participants able to dial in at 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.), and a replay will be available from March 4 to March 18, ensuring that investors who cannot attend live can still access critical information.
- Intellify® Platform Overview: Cross Country Healthcare leverages its Intellify® platform, a cloud-based workforce management and vendor management system, to help healthcare organizations optimize their labor ecosystem, improve resource utilization, and reduce complexity, thereby maintaining a competitive edge in the healthcare industry.
- Company Background and Vision: As a technology-driven company with nearly 40 years of healthcare labor expertise, Cross Country Healthcare aims to help health systems achieve sustainable labor optimization through AI-powered digital platforms and advisory services, enhancing service quality and operational efficiency.
Cross Country Healthcare CEO John Martins Resigns, Names Kevin Clark as Successor
Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Crude Oil Rises More Than 1%; Kroger Stock Declines Following Q3 Earnings Report
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite rising 0.2%, while the Dow fell slightly by 0.04%. Kroger's stock dropped 6% after reporting mixed quarterly results, despite beating earnings expectations.
Sector Movements: Industrials sector shares increased by 0.7%, while consumer staples stocks fell by 1.2%. Notable gainers included Polyrizon Ltd. (up 92%) and UiPath Inc. (up 22%), while Genesco Inc. saw a significant drop of 30%.
Commodity Prices: Oil prices rose by 1.5% to $59.85, while gold increased by 0.2%. In contrast, silver and copper prices fell by 2% and 0.5%, respectively.
Global Market Trends: European shares were generally higher, with the eurozone's STOXX 600 up 0.45%. Asian markets also closed mostly higher, led by Japan's Nikkei, which gained 2.33%.
Cross Country Healthcare Q4 Earnings Preview
- Earnings Announcement Date: Cross Country Healthcare (CCRN) is set to release its Q4 2023 earnings on March 4th after market close, with consensus EPS estimate at $0.03, reflecting a 25% year-over-year decline, and revenue expected at $254.3 million, down 17.9% year-over-year, indicating significant challenges ahead for the company.
- Historical Performance Review: Over the past two years, CCRN has beaten EPS estimates 50% of the time and revenue estimates 63% of the time, suggesting a degree of capability to exceed expectations, yet the recent downward revisions may undermine investor confidence.
- Expectation Revision Trends: In the last three months, EPS estimates have seen one upward revision and three downward revisions, while revenue estimates have experienced no upward revisions and four downward revisions, reflecting a cautious market outlook that could lead to stock price volatility.
- Merger Termination Impact: CCRN recently terminated its merger with Aya Holdings, which will incur a $20 million fee, and while this decision may negatively impact stock prices in the short term, it also provides the company with greater flexibility for future independent growth.
Cross Country Healthcare (CCRN) Earnings Call Transcript
Cross Country Healthcare Q4 Earnings Miss Expectations
- Earnings Miss: Cross Country Healthcare reported a Q4 non-GAAP EPS of -$0.06, missing expectations by $0.09, indicating significant challenges in profitability that could undermine investor confidence.
- Revenue Decline: The company’s Q4 revenue of $236.8M represents a 23.6% year-over-year decline, falling short by $17.5M, reflecting weak market demand and intensified competition, which may hinder future growth prospects.
- Future Guidance: Management's guidance for Q1 2026 revenue is set at $235M to $240M, projecting a year-over-year decline of 20% to 18%, indicating a lack of confidence in short-term recovery, which could affect shareholder investment decisions.
- Adjusted EBITDA Outlook: The expected adjusted EBITDA range of $4.0M to $5.0M reflects a year-over-year decline of 54% to 42%, highlighting significant challenges in cost control and operational efficiency that may impact the company’s competitive position in the market.
Cross Country Healthcare to Hold Q4 2025 Earnings Call
- Earnings Call Scheduled: Cross Country Healthcare will hold a conference call on March 4, 2026, at 5:00 PM ET to discuss its Q4 and full-year 2025 financial results, with the earnings press release set to be distributed after market close, aiming to keep investors informed of the latest financial performance.
- Live Webcast and Replay: The call will be webcast live on the company's website, with participants able to dial in at 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.), and a replay will be available from March 4 to March 18, ensuring that investors who cannot attend live can still access critical information.
- Intellify® Platform Overview: Cross Country Healthcare leverages its Intellify® platform, a cloud-based workforce management and vendor management system, to help healthcare organizations optimize their labor ecosystem, improve resource utilization, and reduce complexity, thereby maintaining a competitive edge in the healthcare industry.
- Company Background and Vision: As a technology-driven company with nearly 40 years of healthcare labor expertise, Cross Country Healthcare aims to help health systems achieve sustainable labor optimization through AI-powered digital platforms and advisory services, enhancing service quality and operational efficiency.
Cross Country Healthcare CEO John Martins Resigns, Names Kevin Clark as Successor
Leadership Change: John Martins has resigned as President and CEO of Cross Country Healthcare, effective December 14, with Kevin Clark appointed as his successor.
Experience of New CEO: Kevin Clark, who co-founded the company and has nearly 40 years of experience in the healthcare staffing industry, will also continue as Chairman of the Board.
Market Reaction: Following the announcement, Cross Country Healthcare's stock rose by 4.83% to $8.90 in pre-market trading on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Crude Oil Rises More Than 1%; Kroger Stock Declines Following Q3 Earnings Report
U.S. Stock Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite rising 0.2%, while the Dow fell slightly by 0.04%. Kroger's stock dropped 6% after reporting mixed quarterly results, despite beating earnings expectations.
Sector Movements: Industrials sector shares increased by 0.7%, while consumer staples stocks fell by 1.2%. Notable gainers included Polyrizon Ltd. (up 92%) and UiPath Inc. (up 22%), while Genesco Inc. saw a significant drop of 30%.
Commodity Prices: Oil prices rose by 1.5% to $59.85, while gold increased by 0.2%. In contrast, silver and copper prices fell by 2% and 0.5%, respectively.
Global Market Trends: European shares were generally higher, with the eurozone's STOXX 600 up 0.45%. Asian markets also closed mostly higher, led by Japan's Nikkei, which gained 2.33%.
